Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Schizophrénie et troubles neurodéveloppementaux

2013

Burt M. A., Tse Y. C., Boksa P., Wong T. (2013). Prenatal immune activation interacts with stress and corticosterone exposure later in life to modulate N-methyl-d-aspartate receptor synaptic function and plasticity, Int J Neuropsychopharmacol, 1-14. En savoir plus.

Capo-Chichi J. M., Tcherkezian J., Hamdan F. F., Decarie J. C., Dobrzeniecka S., Patry L., Nadon M. A., Mucha B. E., Major P., Shevell M., Bencheikh B. O., Joober R., Samuels M. E., Rouleau G. A., Roux P. P., Michaud J. L. (2013). Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly, J Med Genet, 50(11), 740-4. En savoir plus.

Cardoso C., Ellenbogen M. A., Orlando M. A., Bacon S. L., Joober R. (2013). Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study, Psychoneuroendocrinology, 38(3), 399-407. En savoir plus.

Cassoff J., Knauper B., Michaelsen S., Gruber R. (2013). School-based sleep promotion programs: effectiveness, feasibility and insights for future research, Sleep Med Rev, 17(3), 207-214. En savoir plus.

Choudhry Z., Sengupta S.M., Grizenko N., Harvey W.J., Fortier M.E., Schmitz N., Joober R. (2013). Body Weight and ADHD: Examining the Role of Self-Regulation, PLoS ONE, 8(1), e55351. En savoir plus.

Choudhry Z., Sengupta S.M., Grizenko N., Thakur G.A., Fortier M.E., Schmitz N., Joober R. (2013). Association between obesity-related gene FTO and ADHD, Obesity (Silver Spring). En savoir plus.

Chue P., Malla A., Bouchard R. H., Lessard S., Ganesan S., Stip E., Johnson S., Chen E., Ahn Y. M., Kim Y. S., Robinson G., Schweikert C., Gendron A., Eriksson H. (2013). The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia, Curr Med Res Opin, 29(3), 227-39. En savoir plus.

Ciampi A., Yang L., Labbe A., Merette C. (2013). PLS Regression and Hybrid Methods in Genomics Association Studies, , 56, 107-116 .

Cortese S., Brown T. E., Corkum P., Gruber R., O'Brien L. M., Stein M., Weiss M., Owens J. (2013). Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 52(8), 784-96. En savoir plus.

Dancause K.N., Veru F., Andersen R.E., Laplante D., King S. (2013). Prenatal stress due to a natural disaster predicts insulin secretion in adolescence, Early human development. En savoir plus.

Debruille J., Rodier M., Prevost M., Lionnet C., Molavi S. (2013). Effects of a small dose of olanzapine on healthy subjects according to their schizotypy: An ERP study using a semantic categorization and an oddball task, Eur Neuropsychopharmacol, 23(5), 339-50. En savoir plus.

Diaz S. L., Narboux-Neme N., Trowbridge S., Scotto-Lomassese S., Kleine Borgmann F. B., Jessberger S., Giros B., Maroteaux L., Deneris E., Gaspar P. (2013). Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin, Eur J Neurosci, 38(5), 2650-8. En savoir plus.

Ellenbogen M. A., Linnen A. M., Cardoso C., Joober R. (2013). Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms, Psychoneuroendocrinology, 38(3), 387-98. En savoir plus.

Fortier M. E., Sengupta S. M., Grizenko N., Choudhry Z., Thakur G., Joober R. (2013). Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response, Neuromolecular Med, 15(1), 122-32. En savoir plus.

Fortier M. E., Sengupta S. M., Grizenko N., Choudhry Z., Thakur G., Joober R. (2013). Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response, Neuromolecular Med, 15(1), 122-32. En savoir plus.

Gardner D. M., Murphy A. L., Kutcher S., Beaulieu S., Carandang C., Labelle A., Lalonde P., Malla A., Milliken H., O'Donovan C., Schaffer A., Soni J., Taylor V. H., Williams R. (2013). Evidence review and clinical guidance for the use of ziprasidone in Canada, Ann Gen Psychiatry, 12(1), 1. En savoir plus.

Germain J., Bruel-Jungerman E., Grannec G., Denis C., Lepousez G., Giros B., Francis F., Nosten-Bertrand M. (2013). Doublecortin knockout mice show normal hippocampal-dependent memory despite CA3 lamination defects, PLoS One, 8(9), e74992. En savoir plus.

Grizenko N., Cai E., Jolicoeur C., Ter-Stepanian M., Joober R. (2013). Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder, Can J Psychiatry, 58(11), 632-9. En savoir plus.

Grizenko N., Cai E., Jolicoeur C., Ter-Stepanian M., Joober R. (2013). Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder, Can J Psychiatry, 58(11), 632-9. En savoir plus.

Grizenko N., Rodrigues Pereira R. M., Joober R. (2013). Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes, J Can Acad Child Adolesc Psychiatry, 22(2), 153-158. En savoir plus.

Trier par :
Par année :
  2024
  2023
  2022
  2021
  2020
  2019
  2018
  2017
  2016
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001

[+] afficher plus

path
send
share
share